Jeong Heun Ko

Title: Jeong Heun Ko: Innovator in Hepatocellular Carcinoma Diagnostics

Introduction

Jeong Heun Ko is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the detection of hepatocellular carcinoma, a common type of liver cancer. His innovative work has the potential to improve early diagnosis and treatment options for patients.

Latest Patents

Jeong Heun Ko holds a patent for a diagnostic marker for hepatocellular carcinoma, which comprises anti-FASN autoantibodies. The patent details a diagnostic composition that includes antigens related to fatty acid synthase (FASN). This invention focuses on an autoantibody that specifically recognizes the epitope sequence of FASN. The diagnostic kit developed from this invention is designed to assess the expression level of the autoantibody in patients, providing a method for detecting hepatocellular carcinoma effectively.

Career Highlights

Ko is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he has been instrumental in advancing research in bioscience and biotechnology. His work has led to the development of innovative diagnostic tools that can significantly impact patient care in oncology.

Collaborations

Some of his notable coworkers include Eun Wie Cho and Chang Kyu Heo, who have collaborated with him on various research projects. Their combined expertise has contributed to the success of their innovative endeavors.

Conclusion

Jeong Heun Ko's contributions to the field of hepatocellular carcinoma diagnostics exemplify the importance of innovation in medical research. His patented work not only enhances diagnostic capabilities but also paves the way for improved patient outcomes.